COMPARE · Data as of August 27, 2026

BGC vs FUTU

Verdict: Side-by-side breakdown using the Bull Rankings model. BGC scored 77.0, FUTU scored 80.0 — FUTU leads.
Compare another set
BGC
BGC Group, Inc.
Capital Markets · Financial strength
48.1Fin
$12.10 · $5.8B
fundamentals as of
Strength gap
17.5
FUTU leads
FUTU
Futu Holdings Limited
Capital Markets · Financial strength
65.6Fin
$125.01 · $17.5B
  • CheapestFUTU12.5x
THE BULL RANKINGS SCORECARD48.1/ 100 · FIN STRENGTHPEER MEDIANFINANCIAL48.1
THE BULL RANKINGS SCORECARD65.6/ 100 · FIN STRENGTHPEER MEDIANFINANCIAL65.6
P/EBGC30.3xFUTU12.5x
ROEBGC15.9%FUTU30.5%
P/BBGC5.17FUTU3.56
YieldBGC0.7%FUTU2.1%
BGC
FUTU
+30.9%A
Rev
30.3xC
P/E
12.5xB
15.9%B+
ROE
30.5%A
5.17D
P/B
3.56C
0.7%C
Yield
2.1%B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
BGCBGC Group, Inc.
Capital Markets · $12.10 · beta 0.95
Why now
Capital Markets · market cap $5.8b. 6% off the 52-week high of $12.89. Revenue growing +31% — in hypergrowth territory.
Moat
ROE 16% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Trailing P/E 30x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Credit-cycle exposure — provisions tend to lag actual loan deterioration by 2-3 quarters; a sharp uptick in net charge-offs is a leading indicator the market often misses until it's already priced.
FUTUFutu Holdings Limited
Capital Markets · $125.01 · beta 0.43
Why now
Capital Markets · market cap $17.5b. Down 38% from 52-week high of $202.53 — deep drawdown territory. PEG 0.61 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $161.02 (implying +29% upside).
Moat
Net margin 46% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 31% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Down 38% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Duration mismatch — the asset and liability books reprice on different schedules; a rapid move in rates either direction can compress net interest margin before management can reposition.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.